Harmeet Dhillon Scrutinizes the Nation’s Medical Schools
Over the past two decades, the number of U.S. allopathic medical schools accredited by the Liaison Committee on Medical Education has increased from 125 in 2004-05 to 154 in 2024-25.
Professional Regulation
-
Read more: Harmeet Dhillon Scrutinizes the Nation’s Medical Schools -
Read more: Xavier Ochsner College of Medicine: A New Medical School for Black Students Xavier Ochsner College of Medicine: A New Medical School for Black Students
In the state of Louisiana, 32.6 percent of the population identify as Black, while 8.3 percent of the state’s physicians identify as Black. Across the nation, 13.7 percent of the population identify as Black, while 5.7 percent of physicians identify as Black.
-
Read more: Medical Education and Health Care in a Just Society Medical Education and Health Care in a Just Society
The U.S. Department of Justice (DOJ), representing the president’s administration, has taken aim at three of the nation’s top medical schools.
-
Read more: The Guardians of Professional Knowledge The Guardians of Professional Knowledge
Early in the second Trump administration, health information started to disappear from government websites including those maintained by the CDC and NIH. Commentators have begun to wonder how to protect the agencies themselves and what role the health professions might play in responding to rapid changes in health policy and the federal government’s relationship to…
-
Read more: Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing
What challenges arise for bioethicists when taking on commissions to work for organizations that are emerging out of the psychedelic underground?
-
Read more: Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype
As we move past a phase of “partial eclipse” by psychedelic hype, this critical field is finally well-situated to explore the full spectrum of psychedelic effects.
-
Read more: AI, Copyright, and Open Science: Health Implications of the New York Times/OpenAI Lawsuit AI, Copyright, and Open Science: Health Implications of the New York Times/OpenAI Lawsuit
A rundown of the major legal questions at play in the New York Times-OpenAI lawsuit.
-
Read more: The NCAA May Pay a Healthy Sum to Student Athletes The NCAA May Pay a Healthy Sum to Student Athletes
The challenge of student-athlete compensation is a broader issue rooted in more than a century of health policy.
-
Read more: The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
Scholars, analysts, and companies cannot agree on what Amgen v. Sanofi means for patients, drug makers, and innovation.
-
Read more: Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling Don’t Be Too Alarmed by the New SCOTUS Antibody Ruling
SCOTUS revisits enablement, but Amgen v. Sanofi probably won’t transform patent law on its own.
